Quality of life after bladder cancer (Q-ABC)

Not Applicable

Completed

• Conditions: Specialty: Cancer, Primary sub-specialty: Bladder Cancer; UKCRC code/ Disease: Cancer/ Malignant neoplasms of urinary tract; Cancer; Bladder Cancer

• Registration Number: ISRCTN13881914
• Lead Sponsor: Brighton and Sussex University Hospitals NHS Trust

Brief Summary

2021 Results article in https://doi.org/10.1016/j.clon.2021.03.016 (added 18/02/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-04-06
• Study Completion: 2017-12-31
• Last Update Posted: 1 March 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Adult patients > 18 years
2. Diagnosis of Muscle invasive bladder cancer
3. Treated with either radical cystectomy or radical (chemo-)radiotherapy between 1 and 2 years prior to study.
4. English speaking sufficient for in depth interview

Carer:
1. Informal carer of a person who fulfils 1-3 above (recognising that this person may no longer fulfil a caring” role but did so during treatment)
2. English speaking sufficient for in depth interview

Exclusion Criteria

Recurrent disease

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life of patients and carers following radical treatment for bladder cancer, explored using interviews, at a single time point between 1-2 years post treatment.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Experience of the decision-making process relating to radical treatment for bladder cancer, explored using interviews, at a single time point between 1-2 years post treatment<br> 2. Comparative experience of patients and carers, explored using interviews, at a single time point between 1-2 years post treatment<br>